August 2012  << Back  

Agomelatine for the treatment of posttraumatic stress disorder: A case report

Domenico De Berardis, MD, PhD

National Health Service, Department of Mental Health, Psychiatric Service of Diagnosis and Treatment, Hospital G. Mazzini, Teramo, Italy, Department of Neurosciences and Imaging, Chair of Psychiatry, Università G. d’Annunzio, Chieti, Italy

Nicola Serroni, MD

National Health Service, Department of Mental Health, Psychiatric Service of Diagnosis and Treatment, Hospital G. Mazzini, Teramo, Italy

Stefano Marini, MD

National Health Service, Department of Mental Health, Psychiatric Service of Diagnosis and Treatment, Hospital G. MazziniTeramo, Italy, Department of Neurosciences and Imaging, Chair of Psychiatry, Università G. d’Annunzio, Chieti, Italy

Francesco Saverio Moschetta, MD

National Health Service, Department of Mental Health, Psychiatric Service of Diagnosis and Treatment, Hospital G. Mazzini, Teramo, Italy

Giovanni Martinotti, MD, PhD

Department of Neurosciences and Imaging, Chair of Psychiatry, Università G. d’Annunzio, Chieti, Italy

Massimo Di Giannantonio, MD

Department of Neurosciences and Imaging, Chair of Psychiatry, Università G. d’Annunzio, Chieti, Italy

KEYWORDS: posttraumatic stress disorder, agomelatine, treatment

ANNALS OF CLINICAL PSYCHIATRY 2012;24(3):241-242

CORRESPONDENCE: Domenico De Berardis, MD, PhD, National Health Service, Department of Mental Health, Psychiatric Service of Diagnosis and Treatment, Hospital G. Mazzini, Piazza Italia 1, 64100 Teramo, Italy, E-MAIL: dodebera@aliceposta.it
Annals of Clinical Psychiatry ©2012 Quadrant HealthCom Inc.

 
Read full article